Pepper Bio

The End of Untreatable.

[Pepper Bio @pepper_bio]

"This emphasis on transomics is the future.” Check out CEO @JonYuHu’s recent interview with @GenomeWeb to learn how Pepper Bio is leveraging transomics to better understand biological processes and develop precision medicine. #DrugDiscovery #Transomics
https://t.co/643rWOcsxT

[Pepper Bio @pepper_bio]

We’ve reached a milestone in our mission to discover new treatments for untreatable diseases. We’re licensing lerociclib from @G1Therapeutics to test it as a new liver cancer therapeutic—and we’re already seeing promising results. More via @FierceBiotech: https://t.co/yuo1Ir72yb

[Pepper Bio @pepper_bio]

Pepper Bio’s Caitlin Brown will be taking part in #REpharmaUSA 🚀 She’ll be looking to dive into AI in drug discovery & precision medicine discussions. Attending? Let's connect!

[Pepper Bio @pepper_bio]

#AI in #biotech: not a cure-all, but a powerful tool when combined with human expertise, leading to breakthroughs in disease treatment. The synergy between AI and scientists' insights is where real magic lies. Dive deeper via @STAT @caseymross https://t.co/qrUq50nc30

[Pepper Bio @pepper_bio]

Exciting developments at @UVACancerCenter! #Machinelearning now identifies high-risk #AML patients by analyzing cancer cell bioactive molecules. Personalized treatment is the future, ensuring safer, more effective care https://t.co/XswyEcFDX2

[Pepper Bio @pepper_bio]

Countdown to #LSXWorld 🚀CEO @jonhuyu is set to speak on optimizing #AI in #biotech & #pharma. Excited to share insights and connect with you there! Will you be attending? Let's meet up!

[Pepper Bio @pepper_bio]

FDA's approval of repotrectinib marks a new chapter in lung cancer therapy, targeting ROS1 fusions with precision. This advancement aligns with our mission—pushing the boundaries of patient-specific treatment and showcasing the power of #precisionmedicine https://t.co/lNESKOYjJW

[Pepper Bio @pepper_bio]

🧬Thank you @HealthTechX for selecting Pepper Bio as a finalist in the Innovator category! We’re dedicated to making ‘untreatable diseases’ a thing of the past. Congrats to our fellow finalists!

[Pepper Bio @pepper_bio]

@Cambridge_Uni's breakthrough in #drugdiscovery with 'chemical reactome' is a leap towards precision and speed, blending AI and automation. It’s a move away from the costly and timely trial-and-error, a path we at Pepper Bio admire and strive to follow. https://t.co/EEIu3cC76e

[Pepper Bio @pepper_bio]

Embracing the transformative power of #AI, we're redefining drug discovery at Pepper Bio with efficiency and precision. Mindful of the challenges, we're committed to ethical innovation.​​ Explore AI's future in healthcare in @ClinicalLeader1: https://t.co/pegFV7iHRS

[Pepper Bio @pepper_bio]

Precision medicine is more than a concept—it's a revolution in healthcare. With a focus on individual biology, we're redefining treatment for complex diseases. Dive into Dr. Jennifer Levin Carter's insights on #precisionmedicine: https://t.co/YVuzZkGR5f

[Pepper Bio @pepper_bio]

@POLITICO discusses @NIH's move towards animal testing alternatives. @SamanthaDStrass explains the FDA catalyst shifting focus from animal models to computational methods for more accurate and cost-effective outcomes https://t.co/6nlo4vwL68

[Pepper Bio @pepper_bio]

With a growth rate of 40.2% and revenue expected to hit $4.9B by 2028, AI is reshaping #precisionmedicine, from molecule design to target research. More in @Politico on AI redefining #drugdiscovery: https://t.co/ziAEvbC6LZ

[Pepper Bio @pepper_bio]

#AI is revolutionizing #clinicaltrials, moving beyond traditional RCTs that slow down therapy development. This isn't just tech evolution, it's a healthcare paradigm shift towards more personalized, efficient treatments. Dive into the full insights: https://t.co/9x4vF7fVxp

[Pepper Bio @pepper_bio]

At #JPM2024, our CEO @jonyuhu shared with @PharmaVoice's @MeaganParrish his perspective on what policies will shape biotech in 2024. '"It's not the first time we've heard of march-in rights, but [they] are more mainstream now,' he says. More here: https://t.co/RqNY7OHGkD

[Samantha Dale Strasser @SamanthaDStrass]

Energized by @pepper_bio's feature in @TechCrunch's Pitch Deck Teardown! @Haje's review of our $6.5M seed pitch highlights our mission to treat untreatable diseases. Haje’s praise of our market size slide reflects our areas of commitment https://t.co/y7sxctmRht

[Pepper Bio @pepper_bio]

Kicking off 2024 with a feature in @TechCrunch's Pitch Deck Teardown! Thanks to @Haje for the insightful review of our $6.5M seed deck. https://t.co/8jc3gUbLxa

[Pepper Bio @pepper_bio]

We’re welcoming Dr. Martin Alexander Gershon (@endeavorfunds), a renowned neuroscientist, oncologist, and investor, as an advisor to our team! Read more here: https://t.co/RJU5ybRevc
#drugdiscovery #biotech #transomics

[Pepper Bio @pepper_bio]

Are you headed to #JPM2024? Meet with our Head of Development, Caitlin Brown! Caitlin can catch you up on Pepper’s pipeline, partnerships, and research developments this year. Send us a DM to connect or email [email protected].

[NFX @NFX]

See how NFX-backed @pepper_bio and @PangeaBiomed are using AI to help develop better cancer drugs in @WSJ:

https://t.co/jrBzHfpkYA

[Pepper Bio @pepper_bio]

“We don’t think the right question is if AI will impact drug discovery, but how and when,” @Jonyuhu said. Jon and @SamanthaDStrass share more on how AI will transform the industry with @BrianPGormley via @WSJ https://t.co/YW8ZVMIjkR